Regeneron Pharmaceuticals
REGN
#290
Rank
A$117.32 B
Marketcap
A$1,110
Share price
-1.23%
Change (1 day)
3.07%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total assets

Total assets on the balance sheet as of December 2025 : A$57.52 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's total assets are A$57.52 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Regeneron Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-12-31A$60.55 B-0.25%
2024-12-31A$60.70 B25.03%
2023-12-31A$48.55 B13.1%
2022-12-31A$42.93 B22.37%
2021-12-31A$35.08 B57.18%
2020-12-31A$22.32 B5.56%
2019-12-31A$21.14 B26.95%
2018-12-31A$16.65 B48.38%
2017-12-31A$11.22 B16.04%
2016-12-31A$9.67 B25.65%
2015-12-31A$7.69 B64.2%
2014-12-31A$4.68 B41.74%
2013-12-31A$3.30 B65.25%
2012-12-31A$2.00 B55.09%
2011-12-31A$1.29 B20.36%
2010-12-31A$1.07 B29.98%
2009-12-31A$0.82 B-19.62%
2008-12-31A$1.02 B-4.14%
2007-12-31A$1.07 B44.28%
2006-12-31A$0.74 B28.24%
2005-12-31A$0.57 B-5.33%
2004-12-31A$0.61 B-5.24%
2003-12-31A$0.64 B-7.17%
2002-12-31A$0.69 B-28.4%
2001-12-31A$0.97 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
A$282.55 B 391.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$157.37 B 173.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
A$127.85 B 122.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$216.05 B 275.56%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$41.75 B-27.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$7.04 B-87.76%๐Ÿ‡บ๐Ÿ‡ธ USA